82 results on '"Fung-Kee-Fung K"'
Search Results
2. A comparison of standard two-dimensional ultrasound to three-dimensional volume sonography for routine second-trimester fetal imaging
- Author
-
Roy-Lacroix, M E, Moretti, F, Ferraro, Z M, Brosseau, L, Clancy, J, and Fung-Kee-Fung, K
- Published
- 2017
- Full Text
- View/download PDF
3. In Utero Enzyme-replacement Therapy for Infantile-onset Pompe Disease.
- Author
-
J. L., Cohen, P., Chakraborty, Fung-Kee-Fung K., M. E., Schwab, D., Bali, Young S. P., M. H., Gelb, H., Khaledi, A., DiBattista, S., Smallshaw, F., Moretti, Wong D., C., Lacroix, D., El Demellawy, K. C., Strickland, J., Lougheed, A., Moon-Grady, B. R., Lianoglou, P., Harmatz, and P. S., Kishnani
- Published
- 2024
- Full Text
- View/download PDF
4. Neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight
- Author
-
Yang, Q, Wen, S W, Chen, Y, Krewski, D, Fung Kee Fung, K, and Walker, M
- Published
- 2006
5. OP15.08: Association between the cerebroplacental ratio and preterm birth
- Author
-
Ramji, N., primary, Bacal, V., additional, Clancy, J., additional, Moretti, F., additional, and Fung-Kee-Fung, K., additional
- Published
- 2018
- Full Text
- View/download PDF
6. OP15.07: Association between the cerebroplacental ratio and fetal growth disorders in monochorionic twins
- Author
-
Ramji, N., primary, Bacal, V., additional, Clancy, J., additional, Moretti, F., additional, and Fung-Kee-Fung, K., additional
- Published
- 2018
- Full Text
- View/download PDF
7. P19.04: The intertwin difference in first trimester nuchal translucency does not predict birthweight discordance in twin pregnancies
- Author
-
Ferraro, Z.M., primary, Wu, K., additional, Zhang, T., additional, Moretti, F., additional, and Fung-Kee-Fung, K., additional
- Published
- 2018
- Full Text
- View/download PDF
8. EP29.09: Preoperative power Doppler score in predicting depth of myometrial invasion in endometrioid type of endometrial carcinoma
- Author
-
Moretti, F., primary, Alhasani, A., additional, Lle, T., additional, and Fung Kee Fung, K., additional
- Published
- 2017
- Full Text
- View/download PDF
9. OP25.09: Cervical length
- Author
-
Moretti, F., primary, Abdul Ghani, S., additional, and Fung Kee Fung, K., additional
- Published
- 2017
- Full Text
- View/download PDF
10. OP07.09: A comparison of risk of malignancy index (RMI‐2) with subjective sonographic assessment of adnexal masses
- Author
-
Moretti, F., primary, Meija, A., additional, Ferraro, Z. M., additional, Zhang, T., additional, Brown‐Broderick, J., additional, Le, T., additional, and Fung Kee Fung, K., additional
- Published
- 2015
- Full Text
- View/download PDF
11. P15.05: First trimester crown–rump length in twin pregnancy as a predictor of birthweight discordance
- Author
-
AlMugbel, M., primary, Ferraro, Z.M., additional, Page, R., additional, Al Abbad, N., additional, Zhang, T., additional, Lepage, N., additional, and Fung Kee Fung, K., additional
- Published
- 2015
- Full Text
- View/download PDF
12. OP07.08: A preliminary comparison of the IOTA simple rules with the risk of malignancy index RMI-2 for the evaluation of adnexal masses within a Canadian tertiary care centre
- Author
-
Moretti, F., primary, Meija, A., additional, Ferraro, Z.M., additional, Zhang, T., additional, Brown-Broderick, J., additional, Jones, G., additional, Le, T., additional, and Fung Kee Fung, K., additional
- Published
- 2015
- Full Text
- View/download PDF
13. P15.11: First trimester nuchal translucency in twin pregnancy as a predictor of birthweight discordance
- Author
-
AlMugbel, M., primary, Ferraro, Z.M., additional, Page, R., additional, Al Abbad, N., additional, Zhang, T., additional, Lepage, N., additional, and Fung Kee Fung, K., additional
- Published
- 2015
- Full Text
- View/download PDF
14. OP23.04: Ergonomic assessment of 2D vs. 3D ultrasound for obstetric imaging using validated Strain Index (SI) and Rapid Upper Limb Assessment (RULA) analyses
- Author
-
Roy-Lacroix, M., primary, Ferraro, Z.M., additional, Brosseau, L., additional, Greville, J., additional, and Fung Kee Fung, K., additional
- Published
- 2014
- Full Text
- View/download PDF
15. P22.04: Second trimester fetal biometric measures: concordance between 2D and 3D technologies
- Author
-
Alshamrani, S., primary, Moretti, F.M., additional, Fung Kee Fung, K., additional, Ferraro, Z.M., additional, and Roy-Lacroix, M., additional
- Published
- 2014
- Full Text
- View/download PDF
16. P19.15: Ultrasound‐guided selective termination in a dichorionic pregnancy following previable preterm premature rupture of membranes: a case report
- Author
-
Roy‐Lacroix, M., primary, Oppenheimer, L., additional, Bonin, B., additional, and Fung Kee Fung, K., additional
- Published
- 2014
- Full Text
- View/download PDF
17. P30.12: Sonographic diagnosis of puerperal uterine inversion aided by colour Doppler mapping
- Author
-
Jalal, E.M., primary, Moretti, F.M., additional, Nogue, K., additional, Walker, M., additional, and Fung Kee Fung, K., additional
- Published
- 2014
- Full Text
- View/download PDF
18. P03.13: Biometric assessment of the fetal cerebellum vermis in the second trimester using 3D ultrasonography
- Author
-
Moretti, F.M., primary, Ferraro, Z.M., additional, Roy-Lacroix, M., additional, and Fung Kee Fung, K., additional
- Published
- 2014
- Full Text
- View/download PDF
19. Prevention of Rh alloimmunization
- Author
-
Joan M.G. Crane, Line Leduc, de la Ronde S, Greg Davies, R. D. Wilson, John Van Aerde, Dan Farine, Fung Kee Fung K, Philip Wyatt, Lisa Keenan-Lindsay, Anthony Armson, Valerie A. Désilets, Gregory J. Reid, Anne M. Summers, Eason E, and David C. Young
- Subjects
Postnatal Care ,medicine.medical_specialty ,Canada ,medicine.medical_treatment ,MEDLINE ,Rho(D) Immune Globulin ,Rh Isoimmunization ,Miscarriage ,Cohort Studies ,Pregnancy ,medicine ,Humans ,Randomized Controlled Trials as Topic ,Blood type ,Placental abruption ,medicine.diagnostic_test ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Prenatal Care ,medicine.disease ,Placenta previa ,External cephalic version ,Amniocentesis ,Gestation ,Female ,business - Abstract
OBJECTIVE To provide guidelines on use of anti-D prophylaxis to optimize prevention of rhesus (Rh) alloimmunization in Canadian women. OUTCOMES Decreased incidence of Rh alloimmunization and minimized practice variation with regards to immunoprophylaxis strategies. EVIDENCE The Cochrane Library and MEDLINE were searched for English-language articles from 1968 to 2001, relating to the prevention of Rh alloimmunization. Search terms included: Rho(D) immune globulin, Rh iso- or allo-immunization, anti-D, anti-Rh, WinRho, Rhogam, and pregnancy. Additional publications were identified from the bibliographies of these articles. All study types were reviewed. Randomized controlled trials were considered evidence of highest quality, followed by cohort studies. Key individual studies on which the principal recommendations are based are referenced. Supporting data for each recommendation is briefly summarized with evaluative comments and referenced. VALUES The evidence collected was reviewed by the Maternal-Fetal Medicine and Genetics Committees of the Society of Obstetricians and Gynaecologists of Canada (SOGC) and quantified using the Evaluation of Evidence guidelines developed by the Canadian Task Force on the Periodic Health Exam. RECOMMENDATIONS 1. Anti-D Ig 300 microg IM or IV should be given within 72 hours of delivery to a postpartum nonsensitized Rh-negative woman delivering an Rh-positive infant. Additional anti-D Ig may be required for fetomaternal hemorrhage (FMH) greater than 15 mL of fetal red blood cells (about 30 mL of fetal blood). Alternatively, anti-D Ig 120 microg IM or IV may be given within 72 hours of delivery, with testing and additional anti-D Ig given for FMH over 6 mL of fetal red blood cells (12 mL fetal blood). (I-A) 2. If anti-D is not given within 72 hours of delivery or other potentially sensitizing event, anti-D should be given as soon as the need is recognized, for up to 28 days after delivery or other potentially sensitizing event. (III-B) 3. There is poor evidence regarding inclusion or exclusion of routine testing for postpartum FMH, as the cost-benefit of such testing in Rh mothers at risk has not been determined. (III-C) 4. Anti-D Ig 300 microg should be given routinely to all Rh-negative nonsensitized women at 28 weeks' gestation when fetal blood type is unknown or known to be Rh-positive. Alternatively, 2 doses of 100-120 microg may be given (120 microg being the lowest currently available dose in Canada): one at 28 weeks and one at 34 weeks. (I-A) 5. All pregnant women (D-negative or D-positive) should be typed and screened for alloantibodies with an indirect antiglobulin test at the first prenatal visit and again at 28 weeks. (III-C) 6. When paternity is certain, Rh testing of the baby's father may be offered to all Rh-negative pregnant women to eliminate unnecessary blood product administration. (III-C) 7. A woman with "weak D" (also known as Du-positive) should not receive anti-D. (III-D) 8. A repeat antepartum dose of Rh immune globulin is generally not required at 40 weeks, provided that the antepartum injection was given no earlier than 28 weeks' gestation. (III-C) 9. After miscarriage or threatened abortion or induced abortion during the first 12 weeks of gestation, nonsensitized D-negative women should be given a minimum anti-D of 120 microg. After 12 weeks' gestation, they should be given 300 microg. (II-3B) 10. At abortion, blood type and antibody screen should be done unless results of blood type and antibody screen during the pregnancy are available, in which case antibody screening need not be repeated. (III-B) 11. Anti-D should be given to nonsensitized D-negative women following ectopic pregnancy. A minimum of 120 microg should be given before 12 weeks' gestation and 300 microg after 12 weeks' gestation. (III-B) 12. Anti-D should be given to nonsensitized D-negative women following molar pregnancy because of the possibility of partial mole. Anti-D may be withheld if the diagnosis of complete mole is certain. (III-B) 13. At amniocentesis, anti-D 300 microg should be given to nonsensitized D-negativeesis, anti-D 300 microg should be given to nonsensitized D-negative women. (II-3B) 14. Anti-D should be given to nonsensitized D-negative women following chorionic villous sampling, at a minimum dose of 120 microg during the first 12 weeks' gestation, and at a dose of 300 microg after 12 weeks' gestation. (II-B) 15. Following cordocentesis, anti-D Ig 300 microg should be given to nonsensitized D-negative women. (II-3B) 16. Quantitative testing for FMH may be considered following events potentially associated with placental trauma and disruption of the fetomaternal interface (e.g., placental abruption, blunt trauma to the abdomen, cordocentesis, placenta previa with bleeding). There is a substantial risk of FMH over 30 mL with such events, especially with blunt trauma to the abdomen. (III-B) 17. Anti-D 120 microg or 300 microg is recommended in association with testing to quantitate FMH following conditions potentially associated with placental trauma and disruption of the fetomaternal interface (e.g., placental abruption, external cephalic version, blunt trauma to the abdomen, placenta previa with bleeding). If FMH is in excess of the amount covered by the dose given (6 mL or 15 mL fetal RBC), 10 microg additional anti-D should be given for every additional 0.5 mL fetal red blood cells. There is a risk of excess FMH, especially when there has been blunt trauma to the abdomen. (III-B) 18. Verbal or written informed consent must be obtained prior to administration of the blood product Rh immune globulin. (III-C) VALIDATION: These guidelines have been reviewed by the Maternal-Fetal Medicine Committee and the Genetics Committee, with input from the Rh Program of Nova Scotia. Final approval has been given by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
- Published
- 2003
20. OP07.01: A comparison of three-dimensional volume sonography to two-dimensional second trimester anatomic surveys in a Canadian healthcare context
- Author
-
Roy-Lacroix, M., primary, Moretti, F., additional, Brosseau, L., additional, Hwang, A., additional, Clancy, J., additional, and Fung Kee Fung, K., additional
- Published
- 2013
- Full Text
- View/download PDF
21. P13.04: Long term follow up of ovarian volume after uterine artery embolization
- Author
-
Jolly, E., primary, Fung Kee Fung, K., additional, Rasuli, P., additional, Goulet, S., additional, Lago, S., additional, and Walker, M., additional
- Published
- 2005
- Full Text
- View/download PDF
22. P08.08: Fine needle aspiration (FNA) of adnexal cysts—2 years' experience by a single operator
- Author
-
Almadani, E., primary, Black, D., additional, and Fung Kee Fung, K., additional
- Published
- 2005
- Full Text
- View/download PDF
23. Malignant fibrous histiocytoma causing fatal ileal perforation.
- Author
-
Raju, G. C., Fung Kee Fung, K., and Naraynsingh, V.
- Subjects
DERMATOFIBROMA ,BODY fluids ,ILEUM ,ABDOMINAL surgery ,DERMIS tumors - Abstract
The article highlights the case of a 76-year-old black man who has malignant fibrous histiocytoma causing fatal ileal perforation. It mentions that 1500 milliliter foul-smelling purulent fluid in the peritoneal cavity and a 7 centimeter diameter necrotic mass in the terminal ileum were diagnosed on the man at emergency laparotomy.
- Published
- 1987
- Full Text
- View/download PDF
24. Improving health equity through sustained academic partnership: development of a maternal-fetal medicine fellowship training program in Western Kenya.
- Author
-
Nding'ori D, Spitzer RF, Songok J, Buitendyk M, Mishra P, Kosgei W, Kipchumba B, Kakuti M, Tonui P, Fung-Kee-Fung K, Leftwich H, Gardner A, Nyongesa P, and Okun N
- Abstract
Low- and middle-income countries are underresourced in subspecialist care. This study describes a unique maternal-fetal medicine clinical fellowship training program at Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret, Western Kenya. The first of its kind in Eastern Africa, it has met with success in the retention of highly qualified practitioners providing complex pregnancy care to a population that has been heretofore underserved., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
25. Delayed-Interval Delivery in Multiple Pregnancy: A Single-Center Experience of Five Cases.
- Author
-
Gadeer RH, Alhinai A, Fung-Kee-Fung K, and Werlang A
- Abstract
Objectives To describe the obstetric management and perinatal outcomes in multiple pregnancies with delayed-interval delivery (DID) of the cotwin in a tertiary hospital. Methods This is a retrospective chart review of all cases of DID between December 2021 and 2022 at The Ottawa Hospital. Five cases of DID were identified and reviewed to obtain information on obstetric management and maternal-neonatal outcomes. We included eligible twins and triplets. No multiples were excluded. We obtained ethics approval for this case series. Results Four sets of dichorionic diamniotic twins and one trichorionic triamniotic triplet were included. Our patients were admitted between 17
3/7 and 215/7 weeks of gestation. We achieved an interval delivery range between 1 and 36 days. Four out of six multiples did not survive in DID. The two surviving newborns were born at 230/7 and 232/7 , stayed in the neonatal intensive care unit (NICU) for 111 and 131 days, discharged with a weight of 3,594 and 2,743 g, respectively. All DID cases were delivered spontaneously except for two patients that required augmentation due to maternal sepsis. Conclusion Despite the high risk of maternal, fetal, and neonatal morbidity and mortality, if delivery of the first twin occurs before 20 gestational weeks, DID could be considered in selected cases to improve outcomes for the cotwin., Competing Interests: Conflict of Interest None declared., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).)- Published
- 2024
- Full Text
- View/download PDF
26. Canadian Association of Radiologists Obstetrics and Gynecology Diagnostic Imaging Referral Guideline.
- Author
-
Hamel C, Amir B, Avard B, Fung-Kee-Fung K, Furey B, Garel J, and Ghandehari H
- Subjects
- Humans, Female, Canada, Pregnancy, Societies, Medical, Radiologists standards, Diagnostic Imaging methods, Diagnostic Imaging standards, Referral and Consultation, Genital Diseases, Female diagnostic imaging, Gynecology standards, Obstetrics standards
- Abstract
The Canadian Association of Radiologists (CAR) Obstetrics and Gynecology Expert Panel consists of radiologists specializing in obstetrics and gynecology, obstetrics and gynecology physicians, a patient advisor, and an epidemiologist/guideline methodologist. After developing a list of 12 clinical/diagnostic scenarios, a systematic rapid scoping review was undertaken to identify systematically produced referral guidelines that provide recommendations for one or more of these clinical/diagnostic scenarios. Recommendations from 46 guidelines and contextualization criteria in the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) for guidelines framework were used to develop 68 recommendation statements across the 12 scenarios related to the evaluation of obstetrics and gynecology clinical and diagnostic scenarios. This guideline presents the methods of development and the imaging recommendations for a variety of obstetrical and gynecological conditions including pregnancy assessment, recurrent first trimester pregnancy loss, post-partum indications, disorders of menstruation, localization of intra-uterine contraceptive device, infertility assessment, assessment of adnexal mass, pelvic pain of presumed gynecological origin, and pelvic floor evaluation., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
27. Guideline No. 448: Prevention of Rh D Alloimmunization.
- Author
-
Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, and Clarke G
- Subjects
- Humans, Female, Pregnancy, Rh-Hr Blood-Group System immunology, Rh Isoimmunization prevention & control, Rho(D) Immune Globulin therapeutic use, Rho(D) Immune Globulin administration & dosage
- Abstract
Objective: This guideline provides recommendations for the prevention of Rh D alloimmunization (isoimmunization) in pregnancy, including parental testing, routine postpartum and antepartum prophylaxis, and other clinical indications for prophylaxis. Prevention of red cell alloimmunization in pregnancy with atypical antigens (other than the D antigen), for which immunoprophylaxis is not currently available, is not addressed in this guideline., Target Population: All Rh D-negative pregnant individuals at risk for Rh D alloimmunization due to potential exposure to a paternally derived fetal Rh D antigen., Outcomes: Routine postpartum and antepartum Rh D immunoprophylaxis reduces the risk of Rh D alloimmunization at 6 months postpartum and in a subsequent pregnancy., Benefits, Harms, and Costs: This guideline details the population of pregnant individuals who may benefit from Rho(D) immune globulin (RhIG) immunoprophylaxis. Thus, those for whom the intervention is not required may avoid adverse effects, while those who are at risk of alloimmunization may mitigate this risk for themselves and/or their fetus., Evidence: For recommendations regarding use of RhIG, Medline and Medline in Process via Ovid and Embase Classic + Embase via Ovid were searched using both the trials and observational studies search strategies with study design filters. For trials, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effects via Ovid were also searched. All databases were searched from January 2000 to November 26, 2019. Studies published before 2000 were captured from the grey literature of national obstetrics and gynaecology specialty societies, luminary specialty journals, and bibliographic searching. A formal process for the systematic review was undertaken for this update, as described in the systematic review manuscript published separately., Validation Methods: The authors rated the quality of evidence and strength of recommendations using the SOGC's modified GRADE approach. See Appendix A (Tables A1 for definitions and A2 for interpretations of strong and conditional [weak] recommendations)., Intended Audience: The intended users of this guideline include prenatal care providers such as obstetricians, midwives, family physicians, emergency room physicians, and residents, as well as registered nurses and nurse practitioners., Tweetable Abstract: An updated Canadian guideline for prevention of Rh D alloimmunization addresses D variants, cffDNA for fetal Rh type, and updates recommendations on timing of RhIG administration., Summary Statements: RECOMMENDATIONS., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
28. Further Along the Yellow Brick Road: Pathway to Progress in Preventing and Treating HDFN.
- Author
-
Fung-Kee-Fung K and Clarke G
- Published
- 2024
- Full Text
- View/download PDF
29. Avancer sur la route de brique jaune : La voie du progrès dans la prévention et le traitement de la MHNN.
- Author
-
Fung-Kee-Fung K and Clarke G
- Published
- 2024
- Full Text
- View/download PDF
30. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
- Author
-
Cohen JL, Chakraborty P, Fung-Kee-Fung K, Schwab ME, Bali D, Young SP, Gelb MH, Khaledi H, DiBattista A, Smallshaw S, Moretti F, Wong D, Lacroix C, El Demellawy D, Strickland KC, Lougheed J, Moon-Grady A, Lianoglou BR, Harmatz P, Kishnani PS, and MacKenzie TC
- Subjects
- Humans, Infant, Glycogen Storage Disease Type II drug therapy
- Abstract
Patients with early-onset lysosomal storage diseases are ideal candidates for prenatal therapy because organ damage starts in utero. We report the safety and efficacy results of in utero enzyme-replacement therapy (ERT) in a fetus with CRIM (cross-reactive immunologic material)-negative infantile-onset Pompe's disease. The family history was positive for infantile-onset Pompe's disease with cardiomyopathy in two previously affected deceased siblings. After receiving in utero ERT and standard postnatal therapy, the current patient had normal cardiac and age-appropriate motor function postnatally, was meeting developmental milestones, had normal biomarker levels, and was feeding and growing well at 13 months of age., (Copyright © 2022 Massachusetts Medical Society.)
- Published
- 2022
- Full Text
- View/download PDF
31. The Association between Intertwin Difference in First Trimester Crown-Rump Length, Nuchal Translucency, and Birth Weight Discordance in Twin Pregnancies: A Retrospective Cohort Study.
- Author
-
Ferraro ZM, Zhang T, Moretti F, and Fung-Kee-Fung K
- Subjects
- Pregnancy, Female, Humans, Crown-Rump Length, Pregnancy Trimester, First, Birth Weight, Retrospective Studies, Ultrasonography, Prenatal, Canada, Pregnancy, Twin, Nuchal Translucency Measurement
- Abstract
Background: Discordant birth weight in twins is linked to poor outcomes and predicting this discrepancy may lead to enhanced screening and surveillance. Our purpose was to quantify the relationship between intertwin nuchal translucency (NT) and crown-rump length (CRL) discordance with birth weight discrepancies ≥ 20%., Methods: We conducted a retrospective cohort study of 887 live twin births delivering at a Canadian tertiary care center over a 7-year period who opted for integrated prenatal screening. Categorical data are presented as numbers and percentages, and continuous data are expressed as means and standard deviations. Chi-square tests, Fisher's Exact tests, or T -test were performed as appropriate. We then used published data and receiver operating curves to determine the optimal thresholds for predicting birth weight discordance based on first trimester intertwin NT differences. These values were used in multivariate logistic regression models accounting for known confounders., Results: Roughly 16% of twin pairs exhibited ≥ 20% difference in birth weight. Twin pairs with a CRL discordance greater than 10% have nearly a 4 times greater likelihood of having a birth weight discordance greater than 20% (OR 3.71, CI 2.24-6.14) while controlling for chorionicity, maternal age, gestational age at delivery, maternal body mass index (BMI), and parity. In these models, intertwin NT discordance ≥ 20% (OR 1.16, CI 0.77-1.77) and NT discordance ≥ 14% (OR 1.08, CI 0.73-1.60) were not statistically significant predictors of twin birth weight differences. However, when evaluating the effect of the larger intertwin NT value corresponding to the 95
th percentile, an NT difference ≥ 0.9 mm was predictive of birth weight discordance ≥ 20% (OR 2.53, CI 1.21-5.29)., Conclusion: Although intertwin CRL and NT discordance measured via ultrasound between 11-14 weeks gestation are related to birth weight discordance, there is uncertainty as to whether twin birth weight differences are related to adverse pregnancy outcomes in this population., Competing Interests: The authors declare that there are no conflicts of interest., (Copyright © 2022 Zachary Michael Ferraro et al.)- Published
- 2022
- Full Text
- View/download PDF
32. "When in Doubt, Ask the Patient": A Quantitative, Patient-Oriented Approach to Formative Assessment of CanMEDS Roles.
- Author
-
Esteves A, McConnell M, Ferretti E, Garber A, and Fung-Kee-Fung K
- Subjects
- Curriculum, Female, Humans, Infant, Newborn, Pregnancy, Reproducibility of Results, Self-Assessment, Clinical Competence, Competency-Based Education
- Abstract
Introduction: Since the introduction of competency-based frameworks into postgraduate medical curricula, educators have struggled to implement robust assessment tools that document the progression of necessary skills. The global movement towards competency-based medical education demands validated assessment tools. Our objective was to provide validity evidence for the Ottawa CanMEDS Competency Assessment Tool (OCCAT), designed to assess clinical performance in the communicator, professional, and health advocate CanMEDS roles., Methods: We developed the OCCAT, a 29-item questionnaire informed by specialty-specific Entrustable Professional Activities and consultation with stakeholders, including patients. Our sample included nine neonatal-perinatal medicine and maternal fetal medicine fellows rotating through antenatal high-risk clinics at the Ottawa Hospital. Following 70 unique encounters, the OCCAT was completed by patients and learners. Generalizability theory was used to determine overall reliability of scores. Differences in self and patient ratings were assessed using analyses of variance., Results: Generalizability analysis demonstrated that both questionnaires produced reliable scores (G-coefficient > 0.9). Self-scores were significantly lower than patient scores across all competencies, F (1, 6) = 13.9, p = .007. Variability analysis demonstrated that trainee scores varied across all competencies, suggesting both groups were able to recognize competencies as distinct and discriminate favorable behaviors belonging to each., Discussion: Our findings lend support to the movement to integrate self-assessment and patient feedback in formal evaluations for the purpose of enriched learner experiences and improved patient outcomes. We anticipate that the OCCAT will facilitate bridging to competency-based medical education., (© 2021 Esteves et al.)
- Published
- 2021
- Full Text
- View/download PDF
33. Antenatal and postpartum prevention of Rh alloimmunization: A systematic review and GRADE analysis.
- Author
-
Hamel C, Esmaeilisaraji L, Thuku M, Michaud A, Sikora L, and Fung-Kee-Fung K
- Subjects
- Female, GRADE Approach, Humans, Pregnancy, Randomized Controlled Trials as Topic, Rh Isoimmunization immunology, Immunologic Factors administration & dosage, Postnatal Care standards, Prenatal Care standards, Rh Isoimmunization prevention & control, Rh-Hr Blood-Group System immunology
- Abstract
Background: Existing systematic reviews of Rh immunoprophylaxis include only data from randomized controlled trials, have dated searches, and some do not report on all domains of risk of bias or evaluate the certainty of the evidence. Our objective was to perform an updated review, by including new trials, any comparative observational studies, and assessing the certainty of the evidence using the GRADE framework., Methods: We searched MEDLINE, Embase and the Cochrane Library from 2000 to November 26, 2019. Relevant websites and bibliographies of systematic reviews and guidelines were searched for studies published before 2000. Outcomes of interest were sensitization and adverse events. Risk of bias was evaluated with the Cochrane tool and ROBINS-I. The certainty of the evidence was performed using the GRADE framework., Results: Thirteen randomized trials and eight comparative cohort studies were identified, evaluating 12 comparisons. Although there is some evidence of beneficial treatment effects (e.g., at 6-months postpartum, fewer women who received RhIg at delivery compared to no RhIg became sensitized [70 fewer sensitized women per 1,000 (95%CI: 67 to 71 fewer); I2 = 73%]), due to very low certainty of the evidence, the magnitude of the treatment effect may be overestimated. The certainty of the evidence was very low for most outcomes often due to high risk of bias (e.g., randomization method, allocation concealment, selective reporting) and imprecision (i.e., few events and small sample sizes). There is limited evidence on prophylaxis for invasive fetal procedures (e.g. amniocentesis) in the comparative literature, and few studies reported adverse events., Conclusion: Serious risk of bias and low to very low certainty of the evidence is found in existing RCTs and comparative observational studies addressing optimal effectiveness of Rh immunoprophylaxis. Guideline development committees should exercise caution when assessing the strength of the recommendations that inform and influence clinical practice in this area., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
34. Intrauterine Interventions for the Treatment of Twin Anemia-Polycythemia Sequence: A Systematic Review.
- Author
-
Hill KM, Masoudian P, Fung-Kee-Fung K, and El Demellawy D
- Subjects
- Female, Fetofetal Transfusion diagnostic imaging, Fetofetal Transfusion therapy, Humans, Pregnancy, Fetofetal Transfusion diagnosis, Pregnancy, Twin, Ultrasonography, Prenatal
- Abstract
Background: Twin anemia-polycythemia sequence (TAPS) is a complication of monochorionic, multiple gestation pregnancies in which blood shunting through placental anastomoses results in chronic anemia in one fetus and chronic polycythemia in another. The outcomes of different treatment modalities for TAPS are not well known., Objective: To determine the outcomes of the intrauterine interventions used to treat TAPS., Study Design: A systematic literature search of MEDLINE, EMBASE, and CENTRAL was performed in June 2016. Primary outcomes were mortality, morbidity, and adverse perinatal outcomes. Data were summarized in the form of weighted means, and statistical difference was determined., Results: Twenty-one articles were identified for inclusion in this review and were composed of 105 cases of TAPS. In the cases presented in the literature, there was no statistically significant difference in mortality, morbidity, or emergent Caesarean section rates between expectant management, intrauterine transfusion (IUT), and laser ablation therapy. Laser ablation therapy and IUT were found to have a significantly lower rate of adverse perinatal outcomes when compared to expectantly managed cases., Conclusions: The literature looking into the treatment of TAPS is very limited, with no randomized controlled trials and only one includable comparative study. Based on the data in the case report and case study literature, there is no mortality difference between any of the treatment modalities. Expectant management may be associated with an increase in adverse perinatal outcomes when compared to laser therapy and IUT. More comparative studies are needed to assist clinicians in adopting an evidence-based approach to the treatment of TAPS., (Copyright © 2019 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
35. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis.
- Author
-
Masoudian P, Nasr A, de Nanassy J, Fung-Kee-Fung K, Bainbridge SA, and El Demellawy D
- Subjects
- Female, Humans, Odds Ratio, Pre-Eclampsia etiology, Pregnancy, Risk Assessment, Risk Factors, Hypertension, Pregnancy-Induced etiology, Oocyte Donation adverse effects
- Abstract
The purpose of this study was to determine whether pregnancies that were achieved via oocyte donation, compared with pregnancies achieved via other assisted reproductive technology methods or natural conception, demonstrate increased risk of preeclampsia or gestational hypertension. Comparative studies of pregnancies that were achieved with oocyte donation vs other methods of assisted reproductive technology or natural conception with preeclampsia or gestational hypertension were included as 1 of the measured outcomes. Abstracts and unpublished studies were excluded. Two reviewers independently selected studies, which were assessed for quality with the use of methodological index for non-randomized studies, and extracted the data. Statistical analysis was conducted. Of the 523 studies that were reviewed initially, 19 comparative studies met the predefined inclusion and exclusion criteria and were included in the metaanalysis, which allowed for analysis of a total of 86,515 pregnancies. Our pooled data demonstrated that the risk of preeclampsia is higher in oocyte-donation pregnancies compared with other methods of assisted reproductive technology (odds ratio, 2.54; 95% confidence interval, 1.98-3.24; P < .0001) or natural conception (odds ratio, 4.34; 95% confidence interval, 3.10-6.06; P < .0001). The risk of gestational hypertension was also increased significantly in oocyte donation pregnancies in comparison with other methods of assisted reproductive technology (odds ratio, 3.00; 95% confidence interval, 2.44-3.70; P < .0001) or natural conception (odds ratio, 7.94; 95% confidence interval, 1.73-36.36; P = .008). Subgroup analysis that was conducted for singleton and multiple gestations demonstrated a similar risk for preeclampsia and gestational hypertension in both singleton and multiple gestations. This metaanalysis provides further evidence that supports that egg donation increases the risk of preeclampsia and gestational hypertension compared with other assisted reproductive technology methods or natural conception., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. The importance of a late first trimester placental sonogram in patients at risk of abnormal placentation.
- Author
-
Moretti F, Merziotis M, Ferraro ZM, Oppenheimer L, and Fung Kee Fung K
- Abstract
Background. Placenta accreta is a potentially life-threatening obstetrical condition and is responsible for many emergency Caesarean hysterectomies. Early prenatal diagnosis may help minimize maternal morbidity and mortality. This report highlights risk factors, early diagnostic findings and complications associated with placenta accreta, and the role of first trimester sonography in diagnosis. Case. A 38-year-old pregnant woman, G2P1L1 with history of one previous Caesarean section, presented with vaginal bleeding at 13 weeks' gestation. Ultrasound examination was highly suspicious of placenta previa with accreta. During an earlier 12-week scan for nuchal translucency measurement, the placenta was suboptimally visualized. She was counselled regarding potential maternal and fetal complications as well as management options. At 33 weeks' gestation Caesarean hysterectomy was performed due to vaginal bleeding. Conclusion. Early ultrasound screening in high-risk patients may be advantageous in order to identify placenta accreta and conduct appropriate patient counseling regarding risks and management options.
- Published
- 2014
- Full Text
- View/download PDF
37. Three new high-prevalence antigens in the Cromer blood group system.
- Author
-
Hue-Roye K, Lomas-Francis C, Belaygorod L, Lublin DM, Barnes J, Chung A, Fung-Kee-Fung K, Kinney J, Goldman-Lavi R, Yahalom V, Poole J, Ivankovic Z, Alcantara D, Bekavac M, Cepulic BG, Velliquette RW, Mason R, and Reid ME
- Subjects
- Animals, Base Sequence, Blood Group Antigens analysis, Blood Group Antigens immunology, CD55 Antigens genetics, CHO Cells, Cricetinae, Cricetulus, DNA, Complementary genetics, Exons genetics, Humans, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Sequence Analysis, DNA, Sequence Deletion genetics, Blood Group Antigens classification, Blood Group Antigens genetics
- Abstract
Background: The Cromer blood group system consists of nine high-prevalence and three low-prevalence antigens carried on decay-accelerating factor (DAF). This report describes three new Cromer high-prevalence antigens, named ZENA, CROV, and CRAM., Study Design and Methods: Sequence analyses were performed on DNA from three probands whose serum samples each contained an alloantibody to a high-prevalence antigen in the Cromer blood group system. Polymerase chain reaction-restriction fragment length polymorphism analysis to detect the mutation encoding the CROV- phenotype was performed on 100 Croatian donors. To map the respective epitopes, DAF deletion mutants were tested by immunoblotting with eluates containing the antibodies., Results: In each proband, sequence analysis revealed a single-nucleotide substitution in DAF: ZENA, 726T>G mutation, predicted change His242Gln; CROV, 466G>A mutation, predicted change Glu156Lys; and CRAM, 740A>G mutation, predicted change Gln247Arg. By analysis of DAF deletion mutants, the CROV antigenic determinant mapped to the complement control protein (CCP) domain 2, which is encoded by exon 3, whereas ZENA and CRAM mapped to CCP4, which is encoded by exon 6., Conclusion: This study describes three novel high-prevalence antigens in the Cromer blood group system each characterized by a predicted single-amino-acid substitution. The antigens have been assigned the following International Society of Blood Transfusion (ISBT) numbers: ZENA is CROM13, CROV is CROM14, and CRAM is CROM15.
- Published
- 2007
- Full Text
- View/download PDF
38. Relationship between intertwin delivery interval and metabolic acidosis in the second twin.
- Author
-
Edris F, Oppenheimer L, Yang Q, Wen SW, Fung Kee Fung K, and Walker M
- Subjects
- Acidosis epidemiology, Adult, Apgar Score, Birth Order, Diseases in Twins epidemiology, Diseases in Twins etiology, Female, Humans, Incidence, Infant, Newborn, Obstetric Labor Complications etiology, Pregnancy, Retrospective Studies, Time Factors, Twins, Acidosis etiology, Delivery, Obstetric adverse effects, Pregnancy, Multiple
- Abstract
This study sought to assess the relationship between intertwin delivery interval (ITDI) and metabolic acidosis in the second twin at birth using a retrospective twin delivery cohort from a tertiary-level teaching hospital. Twin births were identified from an obstetrical database during a 10-year period from 1994 to 2004. Mean arterial cord pH and base deficit among different ITDIs were compared by analysis of variance. Logistic regression models were used to estimate effects of ITDI on metabolic acidosis. The incidence of metabolic acidosis in the second twin was defined as pH < 7.0, and base deficit was defined as >or= 12 mmol/L at birth. After excluding those pregnancies with both twins delivered by cesarean section, birthweight less than 750 g of either twin, antepartum death of either twin, or second twins with missing cord arterial pH, we had 310 twin pairs left for final analysis. Mean pH was significantly lower and base deficit significantly higher for second twin after ITDI exceeded 60 minutes. The incidence of metabolic acidosis increased with increasing ITDI (chi2 test for linear trend, P = 0.02) and the risk of metabolic acidosis (odds ratio, 22.6; 95% confidence interval, 2.5 to 494.1) was increased in the second twins with ITDI longer than 60 minutes compared with those with ITDI less than 15 minutes. The incidence of metabolic acidosis increases with increasing ITDI and there is a statistically significant increased risk of neonatal acidosis after longer than 60 minutes compared with less than 15 minutes of ITDI.
- Published
- 2006
- Full Text
- View/download PDF
39. Impacts of operative delivery for the first twin on neonatal outcomes in the second twin.
- Author
-
Yang Q, Walker MC, Chen XK, Krewski D, Fung Kee Fung K, and Wen SW
- Subjects
- Apgar Score, Cesarean Section, Extraction, Obstetrical, Female, Gestational Age, Humans, Infant, Newborn, Obstetrical Forceps, Pregnancy, Retrospective Studies, Delivery, Obstetric adverse effects, Delivery, Obstetric mortality, Pregnancy Outcome, Twins
- Abstract
We assess the impacts of operative delivery for the first twins with vertex presentation on neonatal outcomes in second twins using the 1995 to 1997 twin registry data of the United States. A total of 102,554 eligible twin pairs with vertex presentation for the first twin were included in the analysis. Of these, 50,748 (49.5%) first twins had a normal vaginal delivery, 43,504 (42.4%) were delivered by cesarean section, and 8302 (8.1%) were delivered by vaginal operation (vacuum extraction or forceps). In term twins, the risks of asphyxia-related mortality (odds ratio [OR], 3.08; 95% CI, 1.07 to 8.45), newborn injury (OR, 2.10; 95% 1.39 to 3.12), low Apgar score at 5 minutes (OR, 1.49; 95% 1.24 to 1.78), and mechanical ventilation use (OR, 1.34; 95% 1.20 to 1.51) were increased in the second twins whose co-twins were delivered by vaginal operation compared with those whose co-twins who had normal vaginal delivery. In contrast, the risks of asphyxia-related mortality (OR, 0.55; 95% 0.17 to 1.57), newborn injury (OR, 0.20; 95% 0.11 to 0.34), low Apgar score at 5 minutes (OR, 0.51; 95% 0.44 to 0.60), and mechanical ventilation use (OR, 0.77; 95% 0.71 to 0.83) were decreased in the second twins whose co-twins were delivered by cesarean section compared with those whose co-twins had a normal vaginal delivery. In conclusion, vaginal operative delivery for the first twins is related to the adverse neonatal outcomes of their co-twins, whereas cesarean delivery for the first twins is associated with the beneficial neonatal outcomes of their co-twins.
- Published
- 2006
- Full Text
- View/download PDF
40. Neonatal mortality and morbidity rates in term twins with advancing gestational age.
- Author
-
Soucie JE, Yang Q, Wen SW, Fung Kee Fung K, and Walker M
- Subjects
- Adolescent, Adult, Apgar Score, Female, Humans, Infant, Newborn, Logistic Models, Male, Morbidity, Respiration, Artificial, Retrospective Studies, United States epidemiology, Gestational Age, Infant Mortality, Twins
- Abstract
Objective: The purpose of this study was to identify the gestational age with the lowest morbidity and mortality rates for twin pregnancies that reach term., Study Design: A retrospective cohort study carried out with 60,443 twin pairs from the United States (1995-1997). Analysis was restricted to pregnancies that had reached at least 37 weeks of gestation; groups were created on the basis of the gestational ages of 37, 38, 39, and > or = 40 weeks. The incidence of death and morbidity were calculated; multiple logistic regression models were used to estimate the independent effect of gestational age for twin A and B., Results: The neonatal mortality rate increased significantly after 40 weeks of gestation (twin A: odds ratio, 3.47 [95% CI, 2.29, 5.38]; twin B, odds ratio, 2.52 [95% CI, 1.75, 3.67]). There was also an increased risk of neonatal morbidity in the > or = 40 weeks of gestation group for twin A and B (Apgar score, < or = 3; odds ratio, 1.88 [95% CI, 1.18, 3.02], 1.74 [95% CI, 1.21, 2.52], respectively). There was a decreased risk of assisted ventilation in the 38 and 39 weeks of gestation group for twin A (odds ratio, 0.86 [95% CI, 0.77, 0.97], odds ratio, 0.83 [95% CI, 0.72, 0.95], respectively) and a decreased risk in the 39 and > or = 40 weeks of gestation groups for twin B (assisted ventilation: odds ratio, 0.83 [95% CI, 0.73, 0.93], odds ratio, 0.81 [95% CI, 0.72, 0.92], respectively)., Conclusion: This study suggests that the optimal date of delivery for twins should be <40 weeks of gestation; there was no compelling evidence for delivering at <38 weeks of gestation.
- Published
- 2006
- Full Text
- View/download PDF
41. The distribution of intra-twin birth weight discordance and its association with total twin birth weight, gestational age, and neonatal mortality.
- Author
-
Tan H, Wen SW, Fung Kee Fung K, Walker M, and Demissie K
- Subjects
- Adult, Cohort Studies, Confidence Intervals, Female, Gestational Age, Humans, Infant, Newborn, Maternal Age, Odds Ratio, Pregnancy, Prenatal Diagnosis, Retrospective Studies, Risk Assessment, Sex Factors, Birth Weight, Infant Mortality, Pregnancy, Multiple, Twins
- Abstract
Objective: To determine an appropriate cutoff value to differentiate physiologic and pathologic birth weight discordance, to determine the prevalence of birth weight discordance > or =25% among twin pregnancies in different sub-populations, and to examine its clinical significance., Study Design: Historical cohort study of 147,262 twin sets registered in the United States between 1995 and 1997., Results: The prevalence of birth weight discordance > or =25% among twin pregnancies was 8.6%. The prevalence of birth weight discordance > or =25% was significantly decreased with increasing total twin birth weight deciles, was more frequently found in twins with discordant gender (9.1%) than in those twins with concordant gender (8.3%) and in mothers whose age was 30 years or older (9.1%) than those of younger mothers (8.1%). Birth weight discordance > or =25% was associated with earlier gestational age at delivery (35.0 weeks versus 36.0 weeks) and higher neonatal mortality (5.4% versus 2.3%) as compared to twins with lower birth weight discordance., Conclusions: The prevalence of birth weight discordance > or =25% among twin pregnancies was 8.6%, which is associated with lower gestational age at delivery and higher neonatal mortality rates, and may represent a pathologic process.
- Published
- 2005
- Full Text
- View/download PDF
42. Neonatal death and morbidity in vertex-nonvertex second twins according to mode of delivery and birth weight.
- Author
-
Yang Q, Wen SW, Chen Y, Krewski D, Fung Kee Fung K, and Walker M
- Subjects
- Adult, Asphyxia Neonatorum mortality, Cesarean Section, Cohort Studies, Diseases in Twins mortality, Female, Humans, Infant, Newborn, Pregnancy, Retrospective Studies, Asphyxia Neonatorum epidemiology, Birth Weight, Delivery, Obstetric methods, Diseases in Twins epidemiology, Labor Presentation, Twins
- Abstract
Objective: The purpose of this study was to assess the risk of neonatal death and morbidity in vertex-nonvertex second twins according to the mode of delivery and birth weight., Study Design: Data from a retrospective cohort study that was based on all twin births in the United States (1995-1997) were used., Results: A total of 15,185 vertex-nonvertex second twins were classified into 3 groups: (1) both twins were delivered by cesarean delivery (37.7%), (2) both twins were delivered vaginally (46.8%), and (3) the second twin was delivered by cesarean delivery after vaginal delivery of the first twin (15.5%). The risk of asphyxia-related neonatal deaths and morbidity was increased in the group in which both twins were delivered vaginally and the group in which both twins were delivered by cesarean delivery. The increase in neonatal death in the group in which both twins were delivered vaginally was stronger in the birth weight of < 1500 g. In contrast, in the group in which both twins were delivered vaginally and the group in which the second twin was delivered by cesarean delivery after the first twin was delivered vaginally, the increase in neonatal morbidity was greater in the group in which the birth weight was 1500 to 4000 g., Conclusion: The risk of neonatal death and morbidity in second-born twins is higher in the group in which both twins were delivered vaginally and the group in which the second twin was delivered by cesarean delivery after the first twin was delivered vaginally compared with the group in which both twins were delivered by cesarean delivery.
- Published
- 2005
- Full Text
- View/download PDF
43. Occurrence and clinical predictors of operative delivery for the vertex second twin after normal vaginal delivery of the first twin.
- Author
-
Yang Q, Wen SW, Chen Y, Krewski D, Fung Kee Fung K, and Walker M
- Subjects
- Adult, Cohort Studies, Delivery, Obstetric methods, Delivery, Obstetric statistics & numerical data, Female, Fetal Distress etiology, Gestational Age, Humans, Infant, Newborn, Male, Obstetric Labor Complications epidemiology, Obstetric Labor Complications etiology, Obstetric Labor Complications surgery, Parity, Pregnancy, Pregnancy Outcome, United States epidemiology, Birth Order, Cesarean Section statistics & numerical data, Fetal Distress epidemiology, Fetal Distress surgery, Labor Presentation, Twins
- Abstract
Objective: This study was undertaken to estimate occurrence and explore clinical predictors of abdominal and vaginal operative delivery in vertex second twin after normal vaginal delivery of the first twin., Methods: Data from a historical cohort study that was based on a twin registry in the United States (1995-1997) were used., Results: Among 42,417 vertex second twins following normal vaginal delivery of the first twins, rates of abdominal and vaginal operative delivery were 6.3% and 8.3%, respectively. Cord prolapse, fetal distress, maternal complications, abnormal labor, and birth weight 25% larger than first twin were the most important predicators for operative deliveries. Fetal distress and cord prolapse had a stronger effect on abdominal than vaginal operative delivery., Conclusion: In general population, abdominal and vaginal operative delivery rates were 6.3% and 8.3%, respectively, in vertex second twin after normal vaginal delivery of the first twin. The most important predictors for operative delivery are cord prolapse and fetal distress.
- Published
- 2005
- Full Text
- View/download PDF
44. Neonatal mortality in second twin according to cause of death, gestational age, and mode of delivery.
- Author
-
Wen SW, Fung Kee Fung K, Oppenheimer L, Demissie K, Yang Q, and Walker M
- Subjects
- Adult, Asphyxia Neonatorum mortality, Cesarean Section, Cohort Studies, Diseases in Twins epidemiology, Female, Humans, Infant, Newborn, Odds Ratio, Pregnancy, Retrospective Studies, Risk Factors, Birth Order, Cause of Death, Delivery, Obstetric methods, Gestational Age, Infant Mortality, Twins
- Abstract
Objective: The purpose of this study was to assess the risk of neonatal death in the second twin., Study Design: We carried out a retrospective cohort study of 128,219 live born second twins in the United States for the years 1995 through 1997. The study subjects were divided into 3 groups: second twins who were delivered by cesarean delivery after vaginal delivery of the first twin (group 1), both twins delivered vaginally (group 2), and both twins delivered by cesarean delivery (group 3)., Results: The risk of asphyxia-related neonatal deaths was increased in groups 1 and 2; the increased risk in group 1 was stronger in term births than in preterm births., Conclusion: The risk of neonatal deaths, especially for term infants with asphyxia-related deaths, is increased for the second twins who are delivered by cesarean delivery after vaginal delivery of the first twins.
- Published
- 2004
- Full Text
- View/download PDF
45. Neonatal morbidity in second twin according to gestational age at birth and mode of delivery.
- Author
-
Wen SW, Fung Kee Fung K, Oppenheimer L, Demissie K, Yang Q, and Walker M
- Subjects
- Adult, Apgar Score, Cesarean Section, Cohort Studies, Female, Humans, Morbidity, Pregnancy, Respiration, Artificial, Risk Factors, Seizures epidemiology, Birth Order, Delivery, Obstetric methods, Diseases in Twins epidemiology, Gestational Age, Twins
- Abstract
Objective: This study was undertaken to assess the risk of neonatal morbidity in the second twins., Study Design: We carried out a cohort study of 128,219 live born second twins in the United States, 1995 through 1997. The study subjects were divided into 3 groups: second twins delivered by cesarean section after vaginal delivery of the first twin (V-C), both twins delivered vaginally (V-V), and both twins delivered by cesarean section (C-C)., Results: The rates of low 5-minute Apgar score, mechanical ventilation, and seizure were higher in the V-C group (8.27%, 13.39%, and 0.31%) than in the V-V (3.07%, 7.51%, and 0.08%) and the C-C (2.66%, 8.53%, and 0.06%) groups. The V-C associated increase in risk remained after adjustment for confounding factors and was more evident at term than preterm., Conclusion: The risk of neonatal morbidity is increased in second twins who had a cesarean section after vaginal delivery of the first twin, especially at term.
- Published
- 2004
- Full Text
- View/download PDF
46. Prevention of Rh alloimmunization: are we there yet?
- Author
-
Fung Kee Fung K
- Subjects
- Female, Humans, Pregnancy, Rh Isoimmunization prevention & control
- Published
- 2003
- Full Text
- View/download PDF
47. Interactive voice response to assess residents' laparoscopic skills: an instrument validation study.
- Author
-
Fung Kee Fung K, Fung Kee Fung M, Bordage G, and Norman G
- Subjects
- Clinical Competence, Gynecologic Surgical Procedures, Gynecology education, Information Systems, Internship and Residency, Obstetric Surgical Procedures, Obstetrics education, Surveys and Questionnaires, Telephone, Voice, Educational Measurement methods, General Surgery education, Laparoscopy
- Abstract
Objective: The study was undertaken to evaluate the psychometric properties of the Interactive Voice Response (IVR) instrument to assess laparoscopic surgical skills of residents., Study Design: Surgical competence of obstetric-gynecologic residents at the University of Ottawa (Canada) was evaluated after observed performance of skills. Three questions addressing general domains of surgical skill were rated per surgery using a 5-point Likert scale: overall, 993 surgical ratings were made by 29 residents and 13 faculty preceptors., Results: With use of a generalizability study, a minimum of 12 preceptor ratings (G=0.80) are needed to obtain reliable measures of residents' surgical skills. Item analysis indicated that the three items on the instrument were highly correlated (Cronbach alpha=.92). Elements of construct validity were evident for diagnostic and simple laparoscopic procedures., Conclusion: The IVR instrument can be a valid and reliable measure of residents' surgical skills. The IVR ratings functioned as a global rating scale, capturing overall elements of surgical skills. The ratings on the IVR tool had construct validity with improved performance with increased surgical training and experience.
- Published
- 2003
- Full Text
- View/download PDF
48. Acquired right ventricular outflow tract obstruction in the recipient twin in twin-twin transfusion syndrome.
- Author
-
Lougheed J, Sinclair BG, Fung Kee Fung K, Bigras JL, Ryan G, Smallhorn JF, and Hornberger LK
- Subjects
- Canada epidemiology, Catheterization, Cause of Death, Disease Progression, Echocardiography, Female, Fetofetal Transfusion physiopathology, Gestational Age, Hemodynamics, Humans, Incidence, Infant, Infant Mortality, Infant, Newborn, Morbidity, Pregnancy, Prevalence, Prognosis, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Ultrasonography, Prenatal, Ventricular Outflow Obstruction diagnosis, Ventricular Outflow Obstruction therapy, Fetofetal Transfusion complications, Ventricular Outflow Obstruction epidemiology, Ventricular Outflow Obstruction etiology
- Abstract
Objectives: The goal of this study was to determine the prevalence and evolution of acquired right ventricular outflow tract obstruction (RVOTO) in the recipient twin in twin-twin transfusion syndrome (TTTS)., Background: Twin-twin transfusion syndrome complicates 4% to 26% of diamniotic monochorionic twin gestations and is associated with high fetal morbidity and mortality. Cardiac dysfunction and biventricular hypertrophy may develop in the recipient twin with the potential for RVOTO., Methods: This was a retrospective review of a two-center experience of TTTS to describe the prevalence and evolution of acquired RVOTO in the recipient twin. Right ventricular outflow tract obstruction was diagnosed or excluded by fetal or postnatal echocardiography or clinical assessment., Results: Of 73 twin pregnancies with TTTS identified between 1994 to 1998, a total of seven (9.6%) were complicated by RVOTO in the recipient twin: two subvalvar/muscular, four valvar and one combined. Of 44 pregnancies with fetal echo, six had in utero RVOTO with antegrade flow diagnosed at gestational ages ranging from 19 to 27 weeks. In utero progression occurred in four cases over a period of four to eight weeks, with the development of RVOT atresia by delivery. Postnatal progression of RVOTO occurred in two cases, one of which required pulmonary balloon valvuloplasty at age two years. Postnatal regression of subvalvar RVOTO occurred in two cases in early infancy. Death related directly or indirectly to the RVOTO occurred in all four patients who developed complete RVOT obliteration., Conclusions: Right ventricular outflow tract obstruction may occur in the recipient twin of at least 9% of pregnancies complicated by TTTS. Right ventricular outflow tract obstruction progression is common in utero and may worsen neonatal outcome.
- Published
- 2001
- Full Text
- View/download PDF
49. Tuberculous meningitis in pregnancy--implications for mother and fetus: case report and literature review.
- Author
-
Prévost MR and Fung Kee Fung KM
- Subjects
- Adult, Anti-Bacterial Agents, Antitubercular Agents analysis, Antitubercular Agents therapeutic use, Delivery, Obstetric, Drug Therapy, Combination therapeutic use, Female, Humans, Infant, Newborn, MEDLINE, Magnetic Resonance Imaging, Milk, Human chemistry, Pregnancy, Pregnancy Complications, Infectious cerebrospinal fluid, Pregnancy Complications, Infectious diagnosis, Tuberculosis, Meningeal cerebrospinal fluid, Tuberculosis, Meningeal diagnosis, Pregnancy Complications, Infectious therapy, Tuberculosis, Meningeal therapy
- Abstract
The objective of this article is to report an illustrative case of tuberculous meningitis in pregnancy and review the recent literature outlining management and outcome of this devastating disease. A MEDLINE database search for English and French language articles dating back to 1966 was conducted and supplemented by reviewing the references of key articles and textbooks. An article was included if it described a case of tuberculous meningitis during pregnancy or explained the management of this disease. The search yielded a total of 17 articles, case reports, and reviews relating to tuberculous meningitis and/or pregnancy. Six authors describe cases and outcomes of tuberculous meningitis during pregnancy to give a total of 55 cases. Twenty-one patients died of their disease (38.2%), while 15 fetal or neonatal deaths have been reported (36.6%). Tuberculous meningitis is an insidious disease presenting a diagnostic challenge to even an astute practitioner. When recognized early and treated effectively with modern antituberculous medication, prognosis for mother and child is greatly improved.
- Published
- 1999
- Full Text
- View/download PDF
50. Actinomycosis of the liver.
- Author
-
Raju GC, Fung Kee Fung K, Jankey N, Busby G, and Naraynsingh V
- Subjects
- Adult, Humans, Male, Actinomycosis pathology, Liver Diseases pathology
- Abstract
We present our first case of actinomycosis in Trinidad and we believe this is also the first reported case of hepatic actinomycosis in the West Indies.
- Published
- 1985
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.